Optigenex Inc. (OPGX)
OTCMKTS · Delayed Price · Currency is USD
0.0003
+0.0001 (50.00%)
At close: Dec 30, 2025
Optigenex Revenue
In the year 2010, Optigenex had annual revenue of $991.25K with 44.17% growth. Optigenex had revenue of $68.13K in the quarter ending December 31, 2010, a decrease of -62.74%.
Revenue
991.25K
Revenue Growth
+112.73%
P/S Ratio
0.00
Revenue / Employee
991.25K
Employees
1
Market Cap
36.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2010 | 991.25K | 303.71K | 44.17% |
| Dec 31, 2009 | 687.55K | 221.58K | 47.55% |
| Dec 31, 2007 | 465.97K | 165.05K | 54.85% |
| Dec 31, 2006 | 300.92K | 23.09K | 8.31% |
| Dec 31, 2005 | 277.83K | -61.23K | -18.06% |
| Dec 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2002 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Response Genetics | 16.62M |
| Todos Medical | 10.75M |
| Medical Imaging | 7.52M |
| HTG Molecular Diagnostics | 6.21M |
| Rosetta Genomics | 2.86M |
| Arrayit | 2.82M |
| Biocept | 1.36M |
| Medivolve | 666.14K |